Clinical outcome of patients undergoing abdominoplasty after massive weight loss.


Journal

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
ISSN: 1878-7533
Titre abrégé: Surg Obes Relat Dis
Pays: United States
ID NLM: 101233161

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 26 11 2018
revised: 20 04 2019
accepted: 04 06 2019
pubmed: 13 7 2019
medline: 28 7 2020
entrez: 13 7 2019
Statut: ppublish

Résumé

Abdominoplasty is one of the most commonly performed surgical procedures to reshape the body contour in patients who have undergone massive weight loss. This study was undertaken to assess the clinical outcome, complication rates, and risk factors for complications of patients undergoing abdominoplasty after massive weight loss. University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Clinical outcome was retrospectively analyzed in 121 patients, who underwent abdominoplasty. The retrospective analysis included demographic data of patients, such as sex, age, body mass index (BMI), and pre-existing illnesses. Moreover, postoperative complications including seroma, hematoma, wound infection, and tissue necrosis were analyzed. In our study cohort, the median age was 43.7 years, the median weight was 94.7 kg, and the median BMI was 32.3 kg/m We found that abdominoplasty is a safe operative procedure. In addition, the risk for complications is significantly increased in the subgroup of diabetic patients and patients with cardiovascular diseases.

Sections du résumé

BACKGROUND BACKGROUND
Abdominoplasty is one of the most commonly performed surgical procedures to reshape the body contour in patients who have undergone massive weight loss.
OBJECTIVES OBJECTIVE
This study was undertaken to assess the clinical outcome, complication rates, and risk factors for complications of patients undergoing abdominoplasty after massive weight loss.
SETTING METHODS
University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
METHOD METHODS
Clinical outcome was retrospectively analyzed in 121 patients, who underwent abdominoplasty. The retrospective analysis included demographic data of patients, such as sex, age, body mass index (BMI), and pre-existing illnesses. Moreover, postoperative complications including seroma, hematoma, wound infection, and tissue necrosis were analyzed.
RESULTS RESULTS
In our study cohort, the median age was 43.7 years, the median weight was 94.7 kg, and the median BMI was 32.3 kg/m
CONCLUSIONS CONCLUSIONS
We found that abdominoplasty is a safe operative procedure. In addition, the risk for complications is significantly increased in the subgroup of diabetic patients and patients with cardiovascular diseases.

Identifiants

pubmed: 31296446
pii: S1550-7289(18)31280-2
doi: 10.1016/j.soard.2019.06.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1362-1366

Informations de copyright

Copyright © 2019 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Pauline Hunecke (P)

Department of Plastic, Reconstructive and Aesthetic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Marianne Toll (M)

Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Oliver Mann (O)

Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Jakob Robert Izbicki (JR)

Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Marco Blessmann (M)

Department of Plastic, Reconstructive and Aesthetic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Katharina Grupp (K)

Department of Plastic, Reconstructive and Aesthetic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. Electronic address: k.grupp@uke.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH